Natural killer T (NKT) cells are innate-like T cells that rapidly recognize pathogens and produce cytokines that shape the ensuing immune response. IL-17-producing NKT cells are enriched in barrier tissues, such as the lung, skin, and peripheral lymph nodes, and the factors that maintain this population in the periphery have not been elucidated. Here we show that NKT17 cells deviate from other NKT cells in their survival requirements. In contrast to conventional NKT cells that are maintained by IL-15, RORct þ NKTcells are IL-15 independent and instead rely completely on IL-7. IL-7 initiates a T-cell receptor-independent (TCR-independent) expansion of NKT17 cells, thus supporting their homeostasis. Without IL-7, survival is dramatically impaired, yet residual cells remain lineage committed with no downregulation of RORct evident. Their preferential response to IL-7 does not reflect enhanced signaling through STAT proteins, but instead is modulated via the PI3K/AKT/mTOR signaling pathway. The ability to compete for IL-7 is dependent on high-density IL-7 receptor expression, which would promote uptake of low levels of IL-7 produced in the non-lymphoid sites of lung and skin. This dependence on IL-7 is also reported for RORct þ innate lymphoid cells and CD4 þ Th17 cells, and suggests common survival requirements for functionally similar cells.
INTRODUCTION
Natural killer T (NKT) cells are lipid antigen-reactive, CD1d-restricted T cells that represent a unique and critical element of the immune repertoire. They respond swiftly to pathogens, either by direct recognition of bacterial glycolipid antigen 1 or indirectly via cytokine and self-lipid antigen ligation 2, 3 and rapidly produce a range of cytokines that can dictate the course of the subsequent immune response.
It has long been known that the range of cytokines produced by NKT cells is exceptionally diverse. More recently, it was observed that they can produce IL-17, a cytokine crucial for host defence against bacterial and fungal infections. [4] [5] [6] [7] These NKT17 cells constitutively express the transcription factor retinoic acid receptor-related orphan receptor gt (RORgt), are NK1.1 negative, and respond to IL-1b and IL-23 by upregulating IL-17. [7] [8] [9] Unlike conventional NKT cells, NKT17 cells are enriched in ''gateway'' tissues such as the lung, skin, and peripheral lymph nodes (pLN), with lower proportions in the spleen and liver, 5, 8 making them well-placed to respond early to a pathogenic insult.
That IL-17 is of clinical importance is now clear, 10 and a role for IL-17-producing NKT cells is now emerging, particularly in the lung. NKT cells have been found to recognize glycolipids from Streptococcus pneumonia, the leading cause of community-acquired pneumonia, and can make IL-17 rapidly in response. 1 There is also evidence they have a key role in ozoneinduced asthma, with both IL-17 and NKT cells required for the airway hyperactivity produced under these conditions. 11 In addition, experimental data indicates a potential role in autoimmune disease, with NKT cells, along with other innate-like T cells, producing a significant proportion of the early IL-17 in the mouse model of multiple sclerosis. 12 NKT17 cells acquire RORgt expression in the thymus, 13 where their developmental decisions are mediated by low expression of Th-POK and SMAD4-dependent TGFb signaling. [14] [15] [16] That NKT17 cells follow distinct developmental pathways and are then distributed differently in the periphery, raises questions about their ensuing maintenance. Homeostasis of NKT cells was found to require IL-15, however NKT17 cells had yet to be identified at this time. 17, 18 In the first study to examine pLN NKT cells, it was found that IL-15Rb expression was very low on NK1.1-negative cells. 8 This was later shown to also be the case for thymic RORgt þ NKT cells 16 and splenic IL-17RB þ NKT cells (of which RORgt þ are a subset). 19 Interestingly, in mice with a mutant form of IL-15, the IL-17RB À cells are the most significantly decreased. 19 These observations strongly suggest that RORgt þ NKT17 cells do not share the same level of dependency on IL-15 as other NKT cells. Consequently, the factors that maintain this population in the periphery are unknown.
Here we show that, in contrast to the bulk of NKT cells, the homeostasis of IL-17-producing RORgt þ NKT cells depends on IL-7 rather than IL-15. After exposure to IL-7, NKT17 cells rapidly initiate cellular proliferation, without the need for TCR-CD1d contact. This activation requires the phosphoinositide 3-kinase (PI3K)/AKT/mTOR signaling pathway and is precisely tuned to the density of cell surface IL-7Ra. Such dense receptor expression allows NKT17 cells to compete successfully for an ''in-demand'' cytokine, and would enable them to take advantage of the low levels of locally produced IL-7 at nonlymphoid sites such as the lung and the skin. (Figure 1a,b) , had minimal expression of CD122, suggesting decreased sensitivity to IL-15. IL-15 is predominantly delivered to cells via transpresentation, whereby IL-15Ra expressed on monocytes, dendritic cells, and parenchymal cells binds and presents IL-15 to target cells, including NKT cells. 20, 21 In order to not discount any potential effect of cis-presentation, we also examined IL-15Ra on NKT cells, but found that it was only expressed at very low levels, and did not differ between RORgt subsets (see Supplementary Figure S1 online).
In line with the variable expression of CD122, we found that IL-15-deficient mice had a significant increase in the proportion of IL-17-producing and RORgt þ NKT cells (Figure 1c,d ). Importantly, unlike total NKT cells, 17 Figure S1 ). We found that RORgt þ NKT cells express higher levels of IL-2Ra (CD25) than RORgt À NKT cells (see Supplementary Figure S1 ), which may counteract the low expression of CD122 to maintain IL-2 responsiveness.
Preferential expansion of IL-17-producing NKT cells after in vivo IL-7 treatment IL-7, another common homeostatic cytokine, is reported to have either no role 18 or a minor role 17 in NKT-cell homeostasis. As RORgt þ NKT cells were not considered in these studies, we re-examined the response of NKT cells to IL-7. Mice were injected with exogenous IL-7 in the form of cytokine/antibody complexes, 22 with control mice receiving IL-2/IL-2 mAb. Cytokine production by purified NKT cells was assessed ex vivo. IL-2-expanded NKT cells showed enhanced production of a variety of Th1 and Th2 cytokines, but interestingly less IL-17, a result reminiscent of that observed with CD4 þ T cells. 23 In stark contrast, only IL-17 was significantly elevated after IL-7 treatment (Figure 2a) . Likewise, intracellular cytokine staining showed that IL-7-expanded NKT cells displayed enhanced synthesis of IL-17 ( Figure 2b) .
This finding raised the question whether IL-7 signaling specifically stimulated IL-17 production or, alternatively, caused selective expansion of IL-17-producing cells. Examining this question showed that IL-7 injection did indeed cause a selective expansion of NKT17 cells, as contained within the CD4 À NK1.1 À subset or directly analyzed by RORgt (Figure 2c and Supplementary Figure S2) . Within the RORgt þ subset, it was the CD4 À fraction that responded preferentially to IL-7. This preferential expansion to IL-7 was highly specific, as it could not be replicated with either IL-2 or IL-15 injections, with both but particularly IL-15, favoring the RORgt À subset (Figure 2d and Supplementary Figure S2 ). Injection of exogenous IL-7 showed that this cytokine specifically targets RORgt þ NKT cells for expansion. Likewise, RORgt þ NKT cells rapidly proliferate in lymphopenic hosts (an environment with elevated IL-7) as demonstrated in Figure 1e . As such, we questioned whether IL-7 is the cytokine responsible for the normal homeostasis and survival of these cells.
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IL-7
À / À mice do have peripheral NKT cells, albeit in reduced numbers. 17 Significantly, we found that the residual NKT cells were totally unable to synthesize IL-17, and instead were biased toward Th1 and Th2 cytokines, as shown by increased proportions of IFNg and IL-13 ( Figure 3a ). This suggests that either IL-7 offers NKT17 cells a functional advantage, or it is involved in their survival. Indeed we found that IL-7 À / À mice have a profound and selective reduction in RORgt þ NKT cells, being barely detectable by flow cytometry in the spleen, liver, and thymus (Figure 3b,c) . Collectively, these findings indicate that IL-7 is obligatory for the development of the IL-17-producing RORgt þ subset of NKT cells.
The above experiments did not reveal whether IL-7 influences the survival of mature RORgt þ NKT cells. To investigate this question, we examined lymphopenia-induced proliferation in IL-7 À / À mice. Proliferation of RORgt À cells was similar in control and IL-7 À / À recipients, although recovery was reduced in the latter (Figure 3d ). In marked contrast, an IL-7-deficient environment was clearly prohibitive for the RORgt þ subset and led to reduced proliferation and negligible total recovery of the injected cells ( Figure 3d) . Hence, as for initial cell formation, the survival and homeostasis of mature RORgt þ NKT cells was critically dependent on contact with IL-7; contact with IL-15 was irrelevant (compare Figure 1e with Figure 3d ; which were part of the same experiment).
Strong IL-7-driven expansion of RORct þ NKT cells is TCR independent and does not reflect enhanced signaling through STAT5 or STAT3
Like memory T cells, NKT-cell homeostasis is reported to be independent of TCR signaling. 17 We found that this also applied to the RORgt þ subset (Figure 4a) . Stimulation of transferred NKT cells with IL-7/IL-7 mAb resulted in rapid proliferation of the RORgt þ subset, irrespective of CD1d availability.
As IL-7 signaling occurs through the Jak/STAT pathway and involves phosphorylation of STAT5 25 and STAT3, 26 the high sensitivity of RORgt þ NKT cells to IL-7 might reflect enhanced STAT phosphorylation. Although we found that IL-15 is more effective at activating STAT5 in RORgt À compared with RORgt þ NKT cells, the inverse was not true for IL-7. After exposure to titrated concentrations of IL-7, STAT5 was rapidly phosphorylated in both RORgt þ and RORgt À NKT cells to an equivalent degree (Figure 4b and Supplementary Figure S3) . Likewise, both subsets showed equivalent sensitivity to STAT3 activation (Figure 4b ). These data imply that a preferential activation of the Jak/STAT pathway is not the mechanism by which IL-7 exerts its superior effects on RORgt þ NKT cells.
IL-7-mediated RORct þ NKT cell expansion requires activation of the PI3K/AKT/mTOR pathway Downstream effects of IL-7 ligation are often mediated by JAK-STAT signaling, however, the PI3K signaling pathway and inhibitory suppressor of cytokine signaling (SOCS) proteins also have a role. 27, 28 As such, the outcome of IL-7 ligation is influenced by several factors. In T cells, the PI3K pathway is primarily activated after engagement of TCR in conjunction with co-stimulatory receptors. 29 Activation after IL-7 signaling alone is much slower in onset (hours rather than minutes), but can initiate cell-cycle entry. 30 We examined PI3K-dependent signaling in purified NKT cells after overnight culture with IL-7. Notably, IL-7 led to far higher phosphorylation of AKT in the RORgt þ subset, without the need for TCR-CD1d interactions (Figure 4c) . Further studies showed that IL-7-induced proliferation of RORgt þ cells was blocked by the PI3K inhibitor, LY294002, and also by the mTOR inhibitor, rapamycin (Figure 4d ). These findings indicate that the strong IL-7-induced proliferation of RORgt þ NKT cells is crucially dependent on the PI3K/AKT/mTOR signaling pathway.
SOCS proteins are lower in RORct
þ compared with RORct À NKT cells
As increased T-cell sensitivity to IL-7 has been associated with lower levels of SOCS1 and SOCS3 proteins, 31, 32 we asked whether the strong reactivity of RORgt þ NKT cells to IL-7 might reflect altered levels of these molecules. Upon analysis, we found that compared with RORgt À NKT cells, the RORgt Figure S4 ). These data show that hyper-responsiveness to IL-7 correlates with a lower intrinsic expression of SOCS3.
High IL-7Ra expression is crucial for the strong proliferative response of RORct þ NKT cells
As IL-7 is a limited resource, an enhanced capacity to bind this cytokine would offer a distinct advantage. Indeed we found that IL-7Ra expression is higher on RORgt þ than RORgt À NKT cells (Figure 5c ). IL-7Ra expression on RORgt þ NKT cells was also much higher than on conventional T cells, e.g. Figure S4) to directly test the effect of receptor density. Significantly, IL-7 induced stronger proliferation of IL-7Ra
INT-HIGH than IL-7Ra LOW cells (Figure 5f ). Hence, both for RORgt þ and RORgt À cells, proliferative responses of NKT subsets to IL-7 correlated directly with surface levels of IL-7R.
IL-7 alone does not induce or stabilize RORct expression in peripheral NKT17 cells
Although not dependent on IL-7 for homeostasis, the moderate response of RORgt À NKT cells to IL-7 led us to question the stability of the RORgt NKT lineage. Considering that 
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RORgt À NKT cells can be induced to make IL-17 in vitro, 33 and innate lymphoid cell RORgt expression may be stabilized by IL-7, 34 we questioned whether constant IL-7 or deprivation of this signal could induce a switch in RORgt expression in NKT cells. RORgt-negative NKT cells were purified from RORgt-GFP (green fluorescent protein) mice, 35 labeled with Cell Trace Violet (CTV), and transferred into congenic B6 mice (Supplementary Figure S4) . Following IL-7/IL-7 mAb treatment, cells again displayed moderate proliferation, but GFP was only detected in an average of 0.5% of donor cells (Figure 5g) , indicating that even high-dose IL-7 was unlikely to induce conversion to RORgt.
We then purified GFP þ (RORgt þ ) NKT cells and transferred them into sublethally irradiated wild-type and IL-7 À / À hosts. After 1 week, cell survival in IL-7 À / À mice was poor, at only a fraction of that recovered from IL-7 replete mice ( Figure 5h ) and comparable to that of RORgt þ cells recovered when bulk NKT cells were transferred (Figure 3d) . Surviving donor cells retained their RORgt expression (Figure 5h ), indicating that NKT17 cells do not ''revert'' to a RORgtnegative state to survive in the absence of IL-7. Intriguingly, when donor mice were pre-treated with high-dose IL-7, subsequent survival of sorted RORgt þ NKT cells in IL-7
mice was similar to that seen in an IL-7-competent environment ( Figure 5h, right panel) . This suggests that IL-7 can potentiate effects on NKT cells that remain long after exposure to the cytokine has ceased. This is reminiscent of the longlasting effects on T cells that has been reported for recombinant human IL-7 therapy. 36 Collectively, these data support the concept that RORgt-expressing NKT17 cells are a defined lineage, with distinct requirements for survival.
DISCUSSION
In order to uphold effective immune responses to an array of pathogens throughout a lifetime, the immune system must maintain its diverse cell types in both number and proportion. It is now known that immune cells are actively maintained by homeostatic mechanisms, that when removed, result in cell death. Conventional naïve T cells require a combination of IL-7 and TCR signaling from self-peptide MHC (major histocompatibility complex) ligands for survival. Maintenance of memory T cells however, is largely MHC independent, and depends on a mixture of IL-15 and IL-7. 37 Likewise, NKT cells do not require contact with antigen to survive. 17 Instead they were found to be primarily dependent on IL-15, with either only a minor role or no contribution from IL-7. 17, 18, 38 We have now shown that RORgt-expressing NKT17 cells depend entirely on IL-7. This absolute requirement for IL-7, and indifference to IL-15, means that these cells are not in competition for resources with the majority of NKT cells. Instead, the dependence on IL-7 reveals a shared characteristic with other IL-17-producing cells, as it has been recently found that Th17 cells 31 and RORgt þ innate lymphoid cells 39 utilize IL-7 for their survival, while IL-17-producing gd T cells 26 also expand when exposed to IL-7.
Our data support the idea of NKT17 cells as a functionally and developmentally distinct lineage. The capacity to produce IL-17 stably resides with the thymic-derived RORgt þ NKT subset, 13 however a recent report suggested that RORgtnegative NKT cells could be driven to produce IL-17 in vitro 33 suggesting that some subset plasticity may exist. Interestingly, RORgt fate-map mice have also revealed that RORgt þ innate lymphoid cells can downregulate RORgt, an event that is determined by the tissue environment and may in part depend on IL-7. 34 In light of these findings, we asked whether IL-7 regulates RORgt expression, and thus lineage stability, rather than NKT17 survival. However, transfer of purified RORgt-GFP NKT cells revealed that these cells do indeed depend on IL-7 for survival, and cannot alter their phenotype to survive in its absence, at least in steady state conditions in the absence of antigenic or inflammatory cytokine challenge. Interestingly, the extended survival of cells pre-treated with IL-7/IL-7 mAb demonstrates that IL-7 can potentiate long-lasting effects. Whether or not this is the outcome of additional signaling events is under investigation.
Why are these IL-17-producing cells particularly sensitive to IL-7 signaling? Evidence from lymphopenic patients introduced the concept that IL-7 is produced constitutively, and is unaltered by external stimuli, characteristics that allow maintenance of a stable lymphocyte pool. 40, 41 This IL-7 is produced by stromal cells in the bone marrow, thymus, and lymph nodes, which allows lymphocytes developing in, or transiting through these tissues to receive survival signals. 42 Intriguingly, early studies also detected IL-7 in non-lymphoid tissues, including the liver, 43 keratinocytes, 44 and intestinal epithelium. 45 New reporter mice have now confirmed these findings, with IL-7 detected in the intestine, skin and liver, and also lung. 46, 47 Furthermore, there is evidence to suggest that this IL-7 production is not impervious to stimuli, but instead can be induced in response to bacterial signals. 46, 48, 49 Considering that IL-17-producing cells, such as NKT17 cells, are enriched in barrier tissues and are important for defence at these locations, it is tempting to speculate that IL-7 at these sites, both steadystate and bacterial-induced, specifically supports NKT17 maintenance and rapid pathogen responsiveness. High-density IL-7Ra on NKT17 cells would presumably help them compete for the limited IL-7 produced in these non-lymphoid tissues.
Although it is not clear why SOCS3 and not SOCS1 is significantly reduced in RORgt þ compared with RORgt À NKT cells, we hypothesize that this outcome may be somewhat similar to that seen in conventional T cells during virus infection. Upon exposure to IL-7, T cells in virus-infected animals were found to downregulate SOCS3 and not SOCS1. 32 Considering that RORgt þ NKT cells are acutely sensitive to IL-7 and require continual exposure to this cytokine to survive, we propose that this exposure leads to the observed downregulation of SOCS3.
In summary, we have determined that unlike conventional NKT cells, NKT17 cells do not require IL-15 for their survival. Instead, IL-7 is an indispensible homeostatic cytokine for NKT17 cells, which is more inline with other IL-17-producing cells, suggesting that functionally similar cells are both kept in balance, and can respond in concert to a pathogenic threat, by competition for a common resource (IL-7). This shared resource niche supports the idea of IL-7R antagonism as a potential approach for IL-17-driven pathology. Young University, UT, USA) was produced in-house as previously described, 50 using recombinant baculovirus encoding histaminetagged mouse CD1d and mouse b2-microglobulin, originally provided by Professor Mitchell Kronenberg (La Jolla Institute for Allergy and Immunology, CA, USA). For detection of p-STAT5 and p-STAT3, cells were surface stained, stimulated with IL-7, IL-2, or IL-15 (10 ng ml À l unless otherwise stated) for 10 min at 37 1C (or overnight for p-AKT) then immediately fixed, permeabilized, and stained with pSTAT-5, p-STAT3, or p-AKT plus RORgt according to the manufacturer's instructions. To detect SOCS1 and SOCS3, fixed and permeabilized cells were stained with rabbit polyclonal anti-SOCS1 (ab3691) and SOCS3 (ab16030) (Abcam, Cambridge, England), followed by anti-rabbit FITC. Samples were analyzed on a CantoII or sorted using a FACSAria (BD Biosciences). Data were analyzed using FloJo software (Treestar, Inc., Ashland, OR).
Cytokine/mAb complexes. rmIL-2, IL-7, or IL-15 (Peprotech, Rocky Hill, NJ) were mixed with anti-IL-2 (JES6-1, eBioscience; S4B6, BD Biosciences) or anti-IL-7 mAb (M25, BioXCell, West Lebanon, NH) or IL-15 Ra/Fc Chimera (R&D Systems) and incubated at 371C for 30 min as described. 51 Mice were injected i.p. with 1 mg cytokine þ 5 mg mAb on 3 consecutive days.
Cytokine measurement. Sorted NKT cells were stimulated with anti-CD3/CD28 (10 mg ml À l ) for 24 h at 371C, after which culture supernatant was assayed using BD Biosciences cytometric bead array flex set for mice. For intracellular cytokine staining, cells were incubated at 37 1C in complete RPMI-1640 medium with phorbyl myristate acetate (10 ng ml À l ) and ionomycin (1 mg ml À 1 ) for 4 h with monensin. Intracellular staining was performed as per the manufacturer's protocol (BD Biosciences).
CFSE and CTV labeling. Lymphocytes were washed once in 0.1% BSA (bovine serum albumin) in PBS (phosphate-buffered saline), and labeled with 5 mM (in vivo analysis) or 2.5 mM (in vitro analysis) CFSE (Molecular Probes), or 10 mM CTV (Molecular Probes) at a density of 1 Â 10 7 cells per ml 0.1% BSA in PBS for 10 min at 37 1C (CFSE) or 20 min at 221C (CTV). The reaction was stopped with RPMI 10% FCS and washed twice.
Adoptive cell transfers. Sorted congenic Ly5.1 þ NKT cells were labeled with CFSE and injected intravenously into C57BL/6, IL-15 À / À , or IL-7 À / À recipient mice sublethally irradiated (550 RAD) 1 day before cell transfer, or non-irradiated C57BL/6 or CD1d À / À recipients. For analysis of homeostatic expansion, spleens and livers were harvested on day 7 and the Ly5.1 þ donor cells quantified using flow cytometry. For analysis of CD1d dependence, mice were injected with IL-7/IL-7 mAb (1 mg/5 mg) on days 1, 2, 3, and anti-CD1d (50 mg) or Rat IgG2b isotype control (50 mg) on days 1 and 3 (for CD1d
À / À and C57BL/6, respectively). Livers were harvested on day 7 and Ly5.1 þ donor cells quantified using flow cytometry.
In vitro proliferation assay. Sorted NKT cells were CFSE labeled and cultured for 72 h with IL-7 (10 ng/ml). In some cases, cells were preincubated with inhibitors for 1 h before the addition of IL-7; LY294002 (5, 10, and 15 mM) (Calbiochem, Darmstadt, Germany) and Rapamycin (25 nM) (Merck). After culture, cells were stained with RORgt antibody, and analyzed by flow cytometry. Figure 2a (adjusted for two hypotheses). Paired t-tests were used to compare the MFI of RORgt þ and RORgt À subsets. Statistical analyses were performed with Graphpad Prism 6.0b software (Graphpad), with differences considered statistically significant at Po0.05.
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